ATI RN · Obstetrics and Pediatrics · Free Pediatric CCRN Practice Questions

Option A: Miosis, partial eyelid ptosis, and anhidrosis on the affected side of the face are classic signs of Horner's syndrome, which occurs due to disruption of sympathetic nerve pathways. This syndrome is characterized by these specific symptoms resulting from the invasion of the sympathetic ganglia by the tumor.

Option B: Chest pain, dyspnea, cough, weight loss, and fever are common symptoms of lung cancer but do not specifically indicate Horner's syndrome. These symptoms are more general and relate to the cancer's progression rather than the specific neurological effects of sympathetic nerve involvement.

Option C: Arm and shoulder pain and atrophy of arm and hand muscles on the affected side may occur due to local tumor effects or nerve compression but do not represent the hallmark signs of Horner's syndrome, which specifically involves ocular and facial symptoms.

Option D: Hoarseness and dysphagia can occur with lung cancer due to tumor invasion or compression of surrounding structures but are not indicative of Horner's syndrome. These symptoms relate to the involvement of the laryngeal nerves rather than sympathetic nerve disruption.

Takeaways: Understanding the signs of Horner's syndrome, such as miosis, ptosis, and anhidrosis, is crucial for recognizing sympathetic nerve involvement in lung cancer, which requires prompt assessment and intervention to manage complications effectively.

Option C: "We will check the monitor several times a day to be sure the alarm is working." This statement reflects the importance of regular monitoring and maintenance of the apnea monitor to ensure its functionality, which is crucial for the safety of the infant at home. Parents should routinely verify that the monitor is operational to respond promptly to any alarms indicating apnea episodes.

Option A: "We can adjust the monitor to eliminate false alarms." Adjusting the monitor settings to eliminate false alarms can compromise the safety of the infant, as it may prevent the detection of genuine apnea events. Parents should not modify the settings without professional guidance.

Option B: "We should sleep in the same bed as our monitored infant." Co-sleeping with an infant on apnea monitoring increases the risk of suffocation and Sudden Infant Death Syndrome (SIDS). Safe sleep practices recommend placing the infant in a separate sleep space.

Option D: "We will place the monitor in the crib with our infant." The monitor should be positioned according to manufacturer guidelines, typically attached to the infant rather than placed in the crib, to ensure accurate readings and alarm functionality.

Takeaways: Regular checks of the apnea monitor are essential for ensuring its functionality and safety, as parents must prioritize airway obstruction and ventilation before responding to alarms to protect the infant's well-being.

Option C: Acute or chronic blood loss is a significant risk factor for pernicious anemia, as it can lead to a decrease in red blood cell production and exacerbate the condition. This type of anemia is often associated with a deficiency in vitamin B12 absorption due to intrinsic factor deficiency, but blood loss can compound the issue by reducing overall hemoglobin levels.

Option A: Positive family history does not directly contribute to the development of pernicious anemia, which is primarily caused by autoimmune factors affecting intrinsic factor production rather than genetic predisposition.

Option B: Infectious agents or toxins are not recognized risk factors for pernicious anemia. This condition is specifically related to vitamin B12 absorption issues rather than infections or environmental toxins.

Option D: Inadequate dietary intake is more relevant to dietary deficiency anemias rather than pernicious anemia, which is characterized by malabsorption of vitamin B12 despite adequate dietary intake due to intrinsic factor deficiency.

Takeaways: Understanding the role of acute or chronic blood loss is crucial for assessing risk factors in pernicious anemia, as it can significantly impact red blood cell production and overall health, necessitating appropriate management strategies for affected individuals.

Option B: Facial edema is a hallmark clinical manifestation of nephrotic syndrome due to significant proteinuria leading to hypoalbuminemia and subsequent fluid retention. This condition results in swelling, particularly around the eyes and face, which is commonly observed in affected children.

Option A: Weight loss does not typically occur in nephrotic syndrome; instead, patients often experience weight gain due to fluid retention. This is a critical distinction in assessing the clinical presentation of the condition.

Option C: Cloudy smoky brown-colored urine is more indicative of hematuria or urinary tract infections rather than nephrotic syndrome, which is characterized by foamy urine due to proteinuria. This misinterpretation can lead to incorrect assessments.

Option D: Fatigue can occur in nephrotic syndrome but is not a primary clinical manifestation. The more prominent signs include edema and changes in urine characteristics, making fatigue a less specific symptom in this context.

Takeaways: Understanding the key clinical manifestations of nephrotic syndrome, particularly the significance of facial edema due to fluid retention and proteinuria, is essential for accurate assessment and management in pediatric patients.

Option C: Low birth weight or premature infants are screened for anemia at birth and again at 6 months of age, as this timing aligns with their growth and development needs. Anemia screening is crucial for early detection and management, ensuring optimal health outcomes in this vulnerable population.

Option A: Screening at 2 months does not align with the recommended guidelines, as infants are typically screened later to monitor for anemia when they are more likely to develop it due to increased iron demands.

Option B: Screening at 4 months is premature for this population, as the standard practice is to wait until 6 months to assess for anemia, allowing for adequate growth and dietary changes.

Option D: Screening at 8 months is too late, as early detection and intervention are essential for low birth weight and premature infants to prevent complications associated with anemia.

Takeaways: Screening for anemia in low birth weight or premature infants occurs at birth and again at 6 months to ensure timely intervention and support for their health needs, which requires appropriate monitoring and nutritional support throughout their early development.